TGM4 and thyroid cancer: In the present study, we clearly showed that thyroid cancers did develop in Ad-TgP-Cre-injected BrafCA mice, indicating that postnatal expression of BRAFV600E alone under physiologic TSH levels is sufficient for thyroid cancer development.